Fundz

Spr Therapeutics, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $18.8 Million

PRIVATESep 21, 2017$15M of $18.8M raised

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Sep 21, 2017)

Round Type

Venture

ClevelandBiotechnologyHealthcareHealth CareMedicalMedical Device

Quick answer

SPR Therapeutics raised $15 Million in a funding round, dated September 21, 2017. SPR Therapeutics is based in Cleveland, Ohio, United States.

How much did SPR Therapeutics raise?
SPR Therapeutics raised $15 Million in a funding round on September 21, 2017.
What does SPR Therapeutics do?
SPR Therapeutics is a Cleveland, OH-based private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain.
Where is SPR Therapeutics based and how big is it?
SPR Therapeutics is based in Cleveland, Ohio, United States. Fundz records about 380 employees.
Who are the decision-makers at SPR Therapeutics?
Fundz holds 1 contact at SPR Therapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as SPR Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Zenflow raised $11M on October 6, 2017.
  • BrainScope raised $16M on September 29, 2017.
  • Avenda Health, Inc. raised $350K (Seed) on September 28, 2017.
  • ORTHALIGN INC raised $7.6M on August 28, 2017.
  • NeuroOne Medical Technologies Corporation raised $150K (Seed) on October 18, 2017.
  • Profound Medical raised $877K (Seed) on October 5, 2017.

Who to call at SPR Therapeutics, and when

A new round usually means SPR Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SPR Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SPR Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SPR Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SPR Therapeutics

Location

22901 MILLCREEK BOULEVARD

Cleveland, Ohio, United States

About

SPR Therapeutics is a Cleveland, OH-based private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SPR Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJosh B., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SPR Therapeutics's next move

See what Strategic adds

SPR Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.